How many employees does PROCEPT BioRobotics Corporation have?

PROCEPT BioRobotics Corporation reported 888 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is up 17.5% from a year earlier.

What is PROCEPT BioRobotics Corporation's revenue per employee?

PROCEPT BioRobotics Corporation brought in $308M of revenue in fiscal Dec 2025, which is $347K per employee. That ranks 28 of 51 companies we track in Medical - Devices, where the median is $352K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

PROCEPT BioRobotics Corporation employees and revenue per employee

PRCT · Medical - Devices · $1.05B market cap

PROCEPT BioRobotics Corporation had 888 employees at the end of fiscal Dec 2025, up 17.5% from a year earlier. Revenue for the year was $308M, up 37.2% from a year earlier, or $347K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

888

+17.5% YoY

Revenue

$308M

+37.2% YoY

Revenue / employee

$347K

Peer median $352K

Rank in industry

28 of 51

Medical - Devices

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2021

Hover a year for the numbers.

PRCT employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	888	$308M	$347K	+17.5%	+37.2%
Dec 2024	756	$224M	$297K	+20.8%	+64.8%
Dec 2023	626	$136M	$218K	+46.3%	+81.6%
Dec 2022	428	$75.0M	$175K	+82.9%	+117.6%
Dec 2021	234	$34.5M	$147K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

PROCEPT BioRobotics Corporation against similar companies

The closest industry peers by revenue, from Medical - Devices.

Company	Employees	Revenue	Revenue / employee	Shape
SIBN SI-BONE, Inc.	376	$201M	$534K	Efficient growth
GKOS Glaukos Corporation	1,094	$507M	$464K	Efficient growth
KIDS OrthoPediatrics Corp.	602	$236M	$393K	Efficient growth
AXGN AxoGen, Inc.	622	$225M	$362K	Hiring ahead
PRCT PROCEPT BioRobotics Corporation	888	$308M	$347K	Efficient growth
TCMD Tactile Systems Technology, Inc.	1,086	$330M	$303K	Efficient growth
CTKB Cytek Biosciences, Inc.	702	$201M	$287K	Hiring ahead
AORT Artivion, Inc.	1,800	$441M	$245K	Efficient growth
ESTA Establishment Labs Holdings Inc.	1,004	$211M	$210K	Leaner

Every Healthcare company

Questions about PROCEPT BioRobotics Corporation

How many employees does PROCEPT BioRobotics Corporation have?: PROCEPT BioRobotics Corporation reported 888 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is up 17.5% from a year earlier.
What is PROCEPT BioRobotics Corporation's revenue per employee?: PROCEPT BioRobotics Corporation brought in $308M of revenue in fiscal Dec 2025, which is $347K per employee. That ranks 28 of 51 companies we track in Medical - Devices, where the median is $352K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare PRCT with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in PROCEPT BioRobotics Corporation's annual reports (Form 10-K), latest filed February 26, 2026. This is data, not a recommendation to buy or sell PRCT.